BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33302605)

  • 1. Hereditary Hypertrophic Cardiomyopathy in Children and Young Adults-The Value of Reevaluating and Expanding Gene Panel Analyses.
    Fernlund E; Kissopoulou A; Green H; Karlsson JE; Ellegård R; Årstrand HK; Jonasson J; Gunnarsson C
    Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33302605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and genetic analysis of eight children with Primary hypertrophic cardiomyopathy].
    Sun Q; Wang F; Su L; He K; Li Y; Hao C; Li W; Guo J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Oct; 40(10):1211-1216. PubMed ID: 37730219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.
    Mori AA; Castro LR; Bortolin RH; Bastos GM; Oliveira VF; Ferreira GM; Hirata TDC; Fajardo CM; Sampaio MF; Moreira DAR; Pachón-Mateos JC; Correia EB; Sousa AGMR; Brión M; Carracedo A; Hirata RDC; Hirata MH
    Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole exome sequencing combined with integrated variant annotation prediction identifies a causative myosin essential light chain variant in hypertrophic cardiomyopathy.
    Nomura A; Tada H; Teramoto R; Konno T; Hodatsu A; Won HH; Kathiresan S; Ino H; Fujino N; Yamagishi M; Hayashi K
    J Cardiol; 2016 Feb; 67(2):133-9. PubMed ID: 26443374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
    Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
    Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic anticipation in a special form of hypertrophic cardiomyopathy with sudden cardiac death in a family with 74 members across 5 generations.
    Guo X; Fan C; Wang Y; Wang M; Cai C; Yang Y; Zhao S; Duan F; Li Y
    Medicine (Baltimore); 2017 Mar; 96(11):e6249. PubMed ID: 28296734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome Sequencing Highlights a Potential Role for Concealed Cardiomyopathies in Youthful Sudden Cardiac Death.
    Neves R; Tester DJ; Simpson MA; Behr ER; Ackerman MJ; Giudicessi JR
    Circ Genom Precis Med; 2022 Feb; 15(1):e003497. PubMed ID: 34949102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National Biobank.
    Biddinger KJ; Jurgens SJ; Maamari D; Gaziano L; Choi SH; Morrill VN; Halford JL; Khera AV; Lubitz SA; Ellinor PT; Aragam KG
    JAMA Cardiol; 2022 Jul; 7(7):715-722. PubMed ID: 35583889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy.
    Waldmüller S; Sakthivel S; Saadi AV; Selignow C; Rakesh PG; Golubenko M; Joseph PK; Padmakumar R; Richard P; Schwartz K; Tharakan JM; Rajamanickam C; Vosberg HP
    J Mol Cell Cardiol; 2003 Jun; 35(6):623-36. PubMed ID: 12788380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy.
    Mathew J; Zahavich L; Lafreniere-Roula M; Wilson J; George K; Benson L; Bowdin S; Mital S
    Clin Genet; 2018 Feb; 93(2):310-319. PubMed ID: 29053178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal-to-Noise Analysis Can Inform the Likelihood That Incidentally Identified Variants in Sarcomeric Genes Are Associated with Pediatric Cardiomyopathy.
    Kurzlechner LM; Jones EG; Berkman AM; Tadros HJ; Rosenfeld JA; Yang Y; Tunuguntla H; Allen HD; Kim JJ; Landstrom AP
    J Pers Med; 2022 Apr; 12(5):. PubMed ID: 35629155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Utility of a Phenotype-Enhanced
    Mattivi CL; Bos JM; Bagnall RD; Nowak N; Giudicessi JR; Ommen SR; Semsarian C; Ackerman MJ
    Circ Genom Precis Med; 2020 Oct; 13(5):453-459. PubMed ID: 32894683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The congenital disorder of glycosylation in PGM1 (PGM1-CDG) can cause severe cardiomyopathy and unexpected sudden cardiac death in childhood.
    Fernlund E; Andersson O; Ellegård R; Årstrand HK; Green H; Olsson H; Gunnarsson C
    Forensic Sci Int Genet; 2019 Nov; 43():102111. PubMed ID: 31563034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Evaluation of the Utility of Whole Exome Sequencing in Dilated Cardiomyopathy.
    Ramchand J; Wallis M; Macciocca I; Lynch E; Farouque O; Martyn M; Phelan D; Chong B; Lockwood S; Weintraub R; Thompson T; Trainer A; Zentner D; Vohra J; Chetrit M; Hare DL; James P
    J Am Heart Assoc; 2020 Jan; 9(2):e013346. PubMed ID: 31931689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder.
    Li L; Bainbridge MN; Tan Y; Willerson JT; Marian AJ
    Circ Res; 2017 Mar; 120(7):1084-1090. PubMed ID: 28223422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients.
    Cirino AL; Lakdawala NK; McDonough B; Conner L; Adler D; Weinfeld M; O'Gara P; Rehm HL; Machini K; Lebo M; Blout C; Green RC; MacRae CA; Seidman CE; Ho CY;
    Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 29030401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening.
    Christiaans I; Birnie E; van Langen IM; van Spaendonck-Zwarts KY; van Tintelen JP; van den Berg MP; Atsma DE; Helderman-van den Enden AT; Pinto YM; Hermans-van Ast JF; Bonsel GJ; Wilde AA
    Eur Heart J; 2010 Apr; 31(7):842-8. PubMed ID: 20019025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes.
    Ingles J; Goldstein J; Thaxton C; Caleshu C; Corty EW; Crowley SB; Dougherty K; Harrison SM; McGlaughon J; Milko LV; Morales A; Seifert BA; Strande N; Thomson K; Peter van Tintelen J; Wallace K; Walsh R; Wells Q; Whiffin N; Witkowski L; Semsarian C; Ware JS; Hershberger RE; Funke B
    Circ Genom Precis Med; 2019 Feb; 12(2):e002460. PubMed ID: 30681346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Phenotypic Expression of Mutations in the MYH7, MYBPC3 and TNNT2 Genes in Families with Hypertrophic Cardiomyopathy in the South of Brazil: A Cross-Sectional Study.
    Mattos BP; Scolari FL; Torres MA; Simon L; Freitas VC; Giugliani R; Matte Ú
    Arq Bras Cardiol; 2016 Sep; 107(3):257-265. PubMed ID: 27737317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?
    Lafreniere-Roula M; Bolkier Y; Zahavich L; Mathew J; George K; Wilson J; Stephenson EA; Benson LN; Manlhiot C; Mital S
    Eur Heart J; 2019 Dec; 40(45):3672-3681. PubMed ID: 31170284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.